UTI Healthcare Fund Regular Plan-Growth
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 9.97% at 08 Jun 2026 12:48 PM
UTI Healthcare Fund Regular Plan-Growth: Mutual Fund Overview
UTI Healthcare Fund Regular Plan-Growth is an Sectoral-Pharma mutual fund with over 20.85 years of performance history. The scheme manages an AUM of ₹1143.57 Cr and has a NAV of ₹307.606. It is rated '4' stars by analysts. Investors can begin a SIP with as little as ₹500.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 9.97%.
Fund Details
NAV 307.606
Sub-Type Sectoral-Pharma
Rating 4
Min. SIP Amount ₹500.0
Fund Age(Year) 20.85
Fund Size(in Crores) 1143.57
Fund Performance
1 Month 3.98%
3 Month 9.38%
6 Month 6.8%
1 Year 9.97%
3 Year 25.97%
5 Year 13.92%
Know This Fund
As on 08 Jun 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (95.25%) Market Cap Large Cap 18.2 Mid Cap 39.26 Small Cap 37.8 Top Sectors Healthcare 94.28 Services 0.97 Top Holding Aarti Pharmalabs 0.97 Acutaas Chemicals 0.57 Ajanta Pharma 5.84 Alembic Pharmaceuticals 0.68 Alkem Laboratories 3.21 Anthem Biosciences 2.48 Apollo Hospitals Enterprise 3.54 Aster DM Healthcare 1.99 Aurobindo Pharma 2.46 Biocon 0.63 Caplin Point Laboratories 2.17 Cipla 1.72 Cohance Lifesciences 2.96 Divi's Laboratories 3.45 Dr. Lal Pathlabs 1.2 Dr. Reddy's Laboratories 3.35 Emcure Pharmaceuticals 1.02 Eris Lifesciences 1.56 Fortis Healthcare 3.23 Gland Pharma 3.3 Glenmark Pharmaceuticals 3.35 Global Health 2.06 Ipca Laboratories 2.19 Jubilant Pharmova 0.73 Jupiter Life Line Hospitals 1.94 Krishna Institute 1.34 Laxmi Dental 0.98 Lupin 4.23 Marksans Pharma 1.83 Max Healthcare Institute 3 Metropolis Healthcare 1.61 Orchid Pharma 0.55 Pfizer 1.47 Procter & Gamble Health 2.28 Rainbow Children's 1.58 Sai Life Sciences 2.15 Sanofi Consumer Healthcare India 1.01 Sudeep Pharma 1.99 Sun Pharmaceutical Industries 9.49 Syngene International 0.67 Vijaya Diagnostic Centre 1.31 Viyash Scientific 1.95 Windlas Biotech 1.23
Debt & Others (4.75%) Sector Allocation CBLO 0.01 Net Current Assets 4.74 Debt Credit Ratings Debt Category Others 4.75
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 3.46% Ret 1Y 8.34% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-Growth Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Reinvestment Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 3.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.82%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Kamal Gada
Education Mr. Gada is B.com, CA, CS, & CFA
Experience Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 10
Date of Incorporation 2005-08-01
Total AUM 396629.24
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
UTI Healthcare Fund Regular Plan-Growth FAQs
How to invest in UTI Healthcare Fund Regular Plan-Growth?
Investing in UTI Healthcare Fund Regular Plan-Growth through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for UTI Healthcare Fund Regular Plan-Growth in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of UTI Healthcare Fund Regular Plan-Growth?
The term expense ratio for UTI Healthcare Fund Regular Plan-Growth or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of UTI Healthcare Fund Regular Plan-Growth is 2.82% as of 08 Jun 2026.
What is the NAV of UTI Healthcare Fund Regular Plan-Growth?
The NAV of UTI Healthcare Fund Regular Plan-Growth is ₹307.606 as of 08 Jun 2026.
What is the AUM of UTI Healthcare Fund Regular Plan-Growth?
The AUM (Assets Under Management) of UTI Healthcare Fund Regular Plan-Growth is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of UTI Healthcare Fund Regular Plan-Growth is ₹1143.57 Cr as of 08 Jun 2026.
What is the PE and PB ratio of UTI Healthcare Fund Regular Plan-Growth?
The PE ratio of UTI Healthcare Fund Regular Plan-Growth shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in UTI Healthcare Fund Regular Plan-Growth?
Yes, you can invest in UTI Healthcare Fund Regular Plan-Growth through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of UTI Healthcare Fund Regular Plan-Growth in the last 5 years?
The return of UTI Healthcare Fund Regular Plan-Growth in the last 5 years is 13.92%.
What is the minimum SIP investment required in UTI Healthcare Fund Regular Plan-Growth?
The minimum SIP investment in UTI Healthcare Fund Regular Plan-Growth depends on the fund's scheme rules and usually starts at a small amount. For UTI Healthcare Fund Regular Plan-Growth, the minimum SIP amount is ₹500.0.
What is the current NAV of UTI Healthcare Fund Regular Plan-Growth?
The NAV of UTI Healthcare Fund Regular Plan-Growth, as of 08 Jun 2026, is ₹307.606.
Who manages the UTI Healthcare Fund Regular Plan-Growth?
The fund managers responsible for UTI Healthcare Fund Regular Plan-Growth are:
- Kamal Gada